至本医疗科技（上海）有限公司 是一家科技转化型公司，专注于肿瘤分子生物学技术的研发及临床应用转化。
致力于为每一位癌症患者提供全面准确的分子水平信息，辅助医生的精准治疗。
至本医疗科技在上海创建 6 大自主知识产权平台的基因检测中心；拥有流程一体化等方面 6 项软件著作权专利的信息处理超算中心；国际标准的肿瘤精准研发中心；自主研发的“溯源至本”四大产品系列；业务网络覆盖全国五大区域；溯源至本，以静水流深的态度，开展癌症精准诊疗一体化的市场合作模式。
至本医疗科技，“溯癌症之源，至诊疗之本”。
专注—肿瘤精准医疗检测
引领—国际领先行业标准
践行—正直诚信道德准则
提供—科学严谨检测服务
The OrigiMed is a science and technology transforming company which focuses on developing new technologies and clinical translation for all cancer patients across China. By carrying out comprehensive detection via next generation high-throughput sequencing technologies, we provide personalized treatment options and consulting services for each individual cancer patient. We hold ourselves to a high-level of excellence, striving to create the maximum benefit for patients under the international standardization and quality control system.
Company Details
- Employees
- 140
- Address
- 上海市闵行区浦江镇新骏环路115号3号楼5楼, 上海,上海 201114,china
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.origimed.com/
- Keywords
- 生物科技 and 医疗咨询.
- HQ
- 上海, 上海
至本医疗科技（上海）有限公司 Origimed Questions
至本医疗科技（上海）有限公司 Origimed's website is http://www.origimed.com/
至本医疗科技（上海）有限公司 Origimed's LinkedIn profile is https://cn.linkedin.com/company/%E4%B8%8A%E6%B5%B7%E8%87%B3%E6%9C%AC%E7%94%9F%E7%89%A9%E7%A7%91%E6%8A%80%E6%9C%89%E9%99%90%E5%85%AC%E5%8F%B8
至本医疗科技（上海）有限公司 Origimed has
140 employees.
View email and phone details for 140
employees at 至本医疗科技（上海）有限公司 Origimed.
至本医疗科技（上海）有限公司 Origimed's industry is
Biotechnology Research
至本医疗科技（上海）有限公司 Origimed's top competitors are
Source Explorer®,
Msd,
Clinical Research Dot Pro,
Cntech Flight Training Device,
Viva Biotech,
Stanton Chase Greater China,
Aurexel Lifesciences,
Clinical Research China,
领远信息技术（上海）有限公司,
罗欣药业（上海）有限公司.
至本医疗科技（上海）有限公司 Origimed's categories are Biotechnology Research
